SYNTHON
LIVE

Serial Number

87464096

Owner

SYNTHON B.V.

Attorney

E. Anthony Figg

Filing Date

May 25, 2017

Add to watchlist:

No watchlists yet
View on USPTO

SYNTHON Trademark

Serial Number: 87464096 • Registration: 5923742

SYNTHON is a trademark filed by SYNTHON B.V. on May 25, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

SYNTHON B.V. (3 trademarks)

MICROWEG 22
CM NIJMEGEN 6545 , NL

Entity Type: 16

Synthon Holding B.V. (13 trademarks)

Microweg 22
NL-6545 CM NIJMEGEN , NL

Entity Type: 99

Trademark Details

Filing Date

May 25, 2017

Registration Date

December 3, 2019

Published for Opposition

July 9, 2019

Goods & Services

LEGAL SERVICES RELATING TO OBTAINING PHARMACEUTICAL REGISTRATIONS AND COMPILING PHARMACEUTICAL REGISTRATION FILES; PROVIDING LEGAL SERVICES AND INFORMATION IN THE FIELD OF INTELLECTUAL PROPERTY; LEGAL ADVICE IN THE FIELD OF INTELLECTUAL PROPERTY

TREATMENT OF MATERIALS FOR THE MANUFACTURE OF PHARMACEUTICAL AND BIOPHARMACEUTICAL PREPARATIONS; MANUFACTURE, FOR OTHERS, OF PHARMACEUTICAL AND BIOPHARMACEUTICAL PREPARATIONS AND RAW MATERIALS FOR THE PHARMACEUTICAL INDUSTRY, ALL IN THE FIELD OF TREATMENT OF CANCER, MULTIPLE SCLEROSIS AND DISORDERS OF THE CENTRAL NERVOUS SYSTEM, NEOPLASMS AND AUTOIMMUNE DISEASES AND THOSE INTENDED FOR THE TREATMENT OF KIDNEY AND GENITOURINARY DISORDERS, CARDIOVASCULAR DISORDERS, METABOLIC AND GASTRIC DISORDERS, BLOOD DISORDERS, BONE DISORDERS, HORMONAL DISORDERS, TREATMENT OF PAIN, FUNGAL AND BACTERIAL DISEASES AND PREPARATIONS USED IN THE MANAGEMENT OF ANESTHESIA

OFFICE FUNCTIONS RELATING TO THE REGISTRATION OF PHARMACEUTICAL PREPARATIONS AND COMPONENTS AND PHARMACEUTICAL DRUGS; OFFICE FUNCTIONS RELATING TO OBTAINING PHARMACEUTICAL REGISTRATIONS AND COMPILING PHARMACEUTICAL REGISTRATION FILES; BUSINESS MEDIATION OF AGREEMENTS REGARDING THE PURCHASE, SALE AND LICENSING OF PHARMACEUTICAL REGISTRATIONS AND PHARMACEUTICAL REGISTRATION DOSSIERS; BUSINESS ADVICE AND INFORMATION; BUSINESS CONSULTATION; PROCUREMENT OF CONTRACTS FOR OTHERS FOR THE PURCHASE AND SALE OF GOODS; BUSINESS SERVICES, NAMELY, COMPILING OF PHARMACEUTICAL REGISTRATION DOSSIERS FOR OTHERS

PHARMACEUTICAL PREPARATIONS, SUBSTANCES AND COMPOSITIONS FOR THE TREATMENT OF CANCER, MULTIPLE SCLEROSIS AND DISORDERS OF THE CENTRAL NERVOUS SYSTEM, NEOPLASMS AND AUTOIMMUNE DISEASES AND THOSE INTENDED FOR THE TREATMENT OF KIDNEY AND GENITOURINARY DISORDERS, CARDIOVASCULAR DISORDERS, METABOLIC AND GASTRIC DISORDERS, BLOOD DISORDERS, BONE DISORDERS, HORMONAL DISORDERS, TREATMENT OF PAIN, FUNGAL AND BACTERIAL DISEASES AND PREPARATIONS USED IN THE MANAGEMENT OF ANESTHESIA; BIOLOGICAL AND BIOCHEMICAL DRUG AND CULTURES FOR MEDICAL USE, NAMELY, BIOLOGICAL TISSUE CULTURES FOR MEDICAL PURPOSES; CULTURE FLUIDS FOR CULTIVATING HUMAN, AND ANIMAL CELLS AND PLANTS, PLANT CELLS AND PLANT TISSUES; CULTURE MEDIA FOR CULTIVATING HUMAN, AND ANIMAL CELLS AND PLANTS, PLANT CELLS AND PLANT TISSUES; CULTURE MEDIA FOR USE IN CULTURING EUKARYOTIC CELLS; PHARMACEUTICAL BIOLOGICAL AND BIOCHEMICAL DRUGS FOR THE TREATMENT OF NEOPLASMS AND AUTOIMMUNE DISEASE

Filing History

TEAS SECTION 8 RECEIVED
Nov 21, 2025 ES8R
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Dec 3, 2024 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 21, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Nov 21, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 21, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 21, 2022 REAP
REGISTERED-PRINCIPAL REGISTER
Dec 3, 2019 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Oct 30, 2019 DP1B
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 30, 2019 AITU
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Oct 23, 2019 ASGN
NOTICE OF ALLOWANCE CANCELLED
Sep 17, 2019 IUCN
TEAS DELETE 1(B) BASIS RECEIVED
Sep 17, 2019 D1BR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 16, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 16, 2019 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 3, 2019 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 9, 2019 NPUB
PUBLISHED FOR OPPOSITION
Jul 9, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 19, 2019 NONP
ASSIGNED TO LIE
Jun 3, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
May 21, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
May 21, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 21, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
May 21, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 21, 2019 CNEA
EXPARTE APPEAL TERMINATED
May 2, 2019 EXPT
EXPARTE APPEAL AFFIRMED/REVERSED IN PART
Feb 14, 2019 EXAR
NOTIFICATION OF EXAMINERS STATEMENT E-MAILED
Jul 20, 2018 GNSN
EXAMINERS STATEMENT E-MAILED
Jul 20, 2018 GNES
EXAMINERS STATEMENT - COMPLETED
Jul 20, 2018 CNES
JURISDICTION RESTORED TO EXAMINING ATTORNEY
May 31, 2018 JURT
EX PARTE APPEAL-INSTITUTED
Mar 23, 2018 EXPI
EXPARTE APPEAL RECEIVED AT TTAB
Mar 23, 2018 EXAF
NOTIFICATION OF FINAL REFUSAL EMAILED
Jan 25, 2018 GNFN
FINAL REFUSAL E-MAILED
Jan 25, 2018 GNFR
FINAL REFUSAL WRITTEN
Jan 25, 2018 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 22, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 22, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 22, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 22, 2017 GNRN
NON-FINAL ACTION E-MAILED
Jun 22, 2017 GNRT
NON-FINAL ACTION WRITTEN
Jun 22, 2017 CNRT
ASSIGNED TO EXAMINER
Jun 12, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 1, 2017 NWOS
NEW APPLICATION ENTERED
May 29, 2017 NWAP